Event Calendar

Friday, March 8, 2024

Masterclass in Cardiac Amyloidosis: Disease Spectrum, Diagnosis and Management

Start Date: 3/8/2024 5:00 PM EST
End Date: 3/10/2024 3:00 PM EDT


Organization Name: ASNC

Contact:
ASNC Staff
Email: info@asnc.org
Phone: (703) 459-2555

Masterclass in Cardiac Amyloidosis: Disease Spectrum, Diagnosis and Management. 

Join us March 8-10, 2024 for Masterclass in Cardiac Amyloidosis.

Led by Program Chair, Saurabh Malhotra, MD, MPH, FASNC, this program will focus on:

  • the pathogenesis of cardiac amyloidosis;
  • diagnostic techniques and pitfalls;
  • management strategies;
  • mechanisms to facilitate early diagnosis; and
  • treatment and management.

Masterclass in Cardiac Amyloidosis will feature in-depth sessions led by expert cardiologists, multimodality imagers, hematologists, and neurologists to discuss the disease spectrum, diagnosis, and management of cardiac amyloidosis.

Registration is complimentary!
Who Should Attend?

You should attend this program if you are part of the multidisciplinary care team involved with cardiac amyloidosis patients; primary care, general cardiologists, heart failure specialists, nuclear cardiologists, multimodality imaging cardiologists, hematologists, neurologists, nurse practitioners, physicians assistants and nurses.
Program

The program will consist of five virtual sessions. Only registered participants will have access to view the session recordings.
View the agenda.


Friday, March 8
5:00 PM - 7:10 PM
Session 1: Disease and Pathogenesis


Saturday, March 9
10:00 AM - 3:15 PM
Session 2: Diagnostic Techniques and Pitfalls: A Case-Based Discussion
Session 3: Management


Sunday, March 10
10:00 AM - 3:00 PM
Session 4: Facilitating Diagnosis and Management of ATTR
Session 5: Challenging Case Studies in Amyloidosis

Credits

11* CME and MOC will be offered.

*Credits subject to change.
Program Chair

Saurabh Malhotra, MD, MPH, FASNC
Director, Advanced Cardiac Imaging and Cardiac Stress Testing Laboratory
Cook County Health, Chicago, IL


This program is supported by an unrestricted educational grant from Pfizer.